HK1081543A1 - Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives - Google Patents

Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives

Info

Publication number
HK1081543A1
HK1081543A1 HK06101593A HK06101593A HK1081543A1 HK 1081543 A1 HK1081543 A1 HK 1081543A1 HK 06101593 A HK06101593 A HK 06101593A HK 06101593 A HK06101593 A HK 06101593A HK 1081543 A1 HK1081543 A1 HK 1081543A1
Authority
HK
Hong Kong
Prior art keywords
sub
oxazol
preparing
benzoic acid
acid derivatives
Prior art date
Application number
HK06101593A
Other languages
English (en)
Inventor
Michael R Reeder
Rick J Imbordino
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of HK1081543A1 publication Critical patent/HK1081543A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
HK06101593A 2002-06-20 2006-02-07 Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives HK1081543A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (1)

Publication Number Publication Date
HK1081543A1 true HK1081543A1 (en) 2006-05-19

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06101593A HK1081543A1 (en) 2002-06-20 2006-02-07 Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives

Country Status (18)

Country Link
US (2) US7115747B2 (de)
EP (1) EP1532123B1 (de)
JP (1) JP2005533811A (de)
CN (1) CN1324017C (de)
AT (1) ATE370131T1 (de)
AU (1) AU2003249344A1 (de)
BR (1) BR0312439A (de)
CA (1) CA2489988A1 (de)
CO (1) CO5670350A2 (de)
DE (1) DE60315664D1 (de)
EA (1) EA008389B1 (de)
HK (1) HK1081543A1 (de)
IL (1) IL165763A0 (de)
MX (1) MXPA04012630A (de)
NO (1) NO20045497L (de)
NZ (1) NZ537390A (de)
PL (1) PL374999A1 (de)
WO (1) WO2004000821A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351738B2 (en) * 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
EP1971598A1 (de) 2005-11-21 2008-09-24 Amgen Inc. Beta-sekretase-modulatoren und anwendungsverfahren
US20080277393A1 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal cotainer for hazardous and non-hazardous goods
WO2008147544A1 (en) 2007-05-25 2008-12-04 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US8163909B2 (en) 2007-05-25 2012-04-24 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
EA201100461A1 (ru) 2008-09-11 2011-10-31 Амген Инк. Спиро-трициклические соединения как модуляторы бета-секретазы и способы их использования
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011063272A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
CA2788363A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
AU2011227511B2 (en) 2010-03-15 2014-02-20 Amgen Inc. Spiro-tetracyclic ring compounds as Beta - secretase modulators
EP2547686B1 (de) 2010-03-15 2014-01-22 Amgen Inc. Amino-dihydrooxazin- und amino-dihydrothiazin-spiro-verbindungen als beta-secretase modulatoren und deren medizinische verwendung
WO2012109165A1 (en) 2011-02-07 2012-08-16 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
WO2014078314A1 (en) 2012-11-15 2014-05-22 Amgen Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
MXPA04003245A (es) * 2001-10-04 2004-08-11 Elan Pharm Inc Hidroxipropilaminas.
US7176242B2 (en) * 2001-11-08 2007-02-13 Elan Pharmaceuticals, Inc. N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
IL165763A0 (en) 2006-01-15
US7115747B2 (en) 2006-10-03
CO5670350A2 (es) 2006-08-31
US20070105921A1 (en) 2007-05-10
NZ537390A (en) 2006-07-28
DE60315664D1 (de) 2007-09-27
US20040063965A1 (en) 2004-04-01
NO20045497L (no) 2005-03-07
NO20045497D0 (no) 2004-12-16
ATE370131T1 (de) 2007-09-15
JP2005533811A (ja) 2005-11-10
EP1532123A1 (de) 2005-05-25
MXPA04012630A (es) 2005-09-30
BR0312439A (pt) 2005-05-10
EP1532123B1 (de) 2007-08-15
EA200401510A1 (ru) 2005-06-30
CN1324017C (zh) 2007-07-04
WO2004000821A1 (en) 2003-12-31
EA008389B1 (ru) 2007-04-27
CN1662510A (zh) 2005-08-31
CA2489988A1 (en) 2003-12-31
AU2003249344A1 (en) 2004-01-06
PL374999A1 (en) 2005-11-14

Similar Documents

Publication Publication Date Title
HK1081543A1 (en) Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
MY142768A (en) Gfat inhibitors
MY142807A (en) Benzimidazole derivative and use thereof.
MXPA05011150A (es) 2-hidroxi-3-diaminoalcanos de benzamida.
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
EP1740559A4 (de) Als ?-sekretase-inhibitoren für die behandlung von alzheimer-krankheit geeignete 1,3,5-substituierte phenylderivatverbindungen
EA200101194A1 (ru) Производные 4,5,6,7-тетрагидроиндазола в качестве противоопухолевых средств
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
HK1125358A1 (en) Substituted cyclohexylmethyl derivatives
WO2003103653A8 (en) METHODS OF TREATING ALZHEIMER'S DISEASE WITH ALKANOIC ARYL ACID AMIDES
GEP20074045B (en) (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
PT1709027E (pt) Compostos do tipo hidrazida e sua utilização em composições farmacêuticas para o tratamento de doenças cardiovasculares
PL1685142T3 (pl) Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera
AU2003242144A1 (en) Processes for producing epoxytriazole derivative and intermediate therefor
EP1036793A3 (de) Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
TW200612912A (en) Benzyloxy derivatives as maob inhibitors
MXPA05013732A (es) Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo.
WO2004032854A3 (en) Pharmaceutical compositions for treatment of parkinson's disease
MXPA06004299A (es) Derivados de arilespirofuropiridina.
MXPA05007217A (es) Proceso para la preparacion de derivados de imidazol sustituidos y los productos intermedios usados en este proceso.
WO2004037179A3 (en) Substituted peptides useful in the treatment of alzheimer’s disease
TH77460B (th) สารเชิงการบำบัด

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110620